Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Manic switches induced by antidepressants: an umbrella review comparing randomized controlled trials and observational studies
Nathalie Allain, Cyril Leven, Bruno Falissard, et al.
Acta Psychiatrica Scandinavica (2016) Vol. 135, Iss. 2, pp. 106-116
Open Access | Times Cited: 24

Showing 24 citing articles:

20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings
Taeho Greg Rhee, Mark Olfson, Andrew A. Nierenberg, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 8, pp. 706-715
Open Access | Times Cited: 186
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study
Ingrid Toews, Andrew Anglemyer, John LZ Nyirenda, et al.
Cochrane library (2024) Vol. 2024, Iss. 1
Closed Access | Times Cited: 22
Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort
Çağatay Ermiş, Heidi Taipale, Antti Tanskanen, et al.
The Lancet Psychiatry (2025)
Closed Access | Times Cited: 4
Incidence, prevalence and clinical correlates of antidepressant‐emergent mania in bipolar depression: a systematic review and meta‐analysis
Michele Fornaro, Annalisa Anastasia, Stefano Novello, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 3, pp. 195-227
Closed Access | Times Cited: 71
Antidepressants for Pediatric Patients.
Jennifer B. Dwyer, Michael H. Bloch
Current psychiatry (2019) Vol. 18, Iss. 9, pp. 26
Closed Access | Times Cited: 58
Sleep deprivation as treatment for depression: Systematic review and meta‐analysis
Michael Ioannou, Constanze Wartenberg, Josephine T. V. Greenbrook, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 1, pp. 22-35
Open Access | Times Cited: 53
Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial
Kristen K. Ellard, Emily E. Bernstein, Casey Hearing, et al.
Journal of Affective Disorders (2017) Vol. 219, pp. 209-221
Open Access | Times Cited: 61
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years
Anders Jørgensen, Mathilde Marie Brünnich Sloth, Emma Neble Larsen, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 51-57
Open Access
Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability
Giovanni Martinotti, Chiara Montemitro, Mauro Pettorruso, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 13, pp. 1575-1588
Closed Access | Times Cited: 17
Chronic exposure to imipramine induces a switch from depression-like to mania-like behavior in female serotonin transporter knockout rats: Role of BDNF signaling in the infralimbic cortex
Mina Sadighi, Lingling Mai, Yifan Xu, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 128-142
Open Access | Times Cited: 1
BEEP—Bodily and Emotional Perception of Pain. A Questionnaire to Measure Reaction to Pain in Chronic Pain Disorders
Antonio Preti, Serena Stocchino, Francesco Pinna, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 10
Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review
Ida Seeberg, IB Nielsen, CK Jørgensen, et al.
Journal of Affective Disorders (2020) Vol. 279, pp. 31-45
Closed Access | Times Cited: 9
The Use of Antidepressants in Bipolar Depression
John L. Beyer
Handbook of experimental pharmacology (2018), pp. 415-442
Closed Access | Times Cited: 8
Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain
Taise Possamai‐Della, Gustavo C. Dal‐Pont, Wilson R. Resende, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 12, pp. 7170-7181
Closed Access | Times Cited: 5
Imipramine induces hyperactivity in rats pretreated with ouabain: Implications to the mania switch induced by antidepressants
Samira S. Valvassori, José H. Cararo, Carlos Augusto P. Marino, et al.
Journal of Affective Disorders (2021) Vol. 299, pp. 425-434
Open Access | Times Cited: 6
Neglected but not negligible aspects of antidepressants and their availability in bipolar depression
Takeshi Terao
Brain and Behavior (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 5
Ketamine: A Promising Rapid-Acting Antidepressant
Samuel T. Wilkinson, Robert Ostroff, Rachel B. Katz, et al.
Springer eBooks (2017), pp. 223-239
Closed Access | Times Cited: 4
Working with Anxiety Disorders in Bipolar Disorder
Martin D. Provencher, Laurence Garceau, Steven Jones
(2024), pp. 499-539
Closed Access
VORTIOXETINE-INDUCED HYPOMANIA: A CASE REPORT
Emrah Songur
Psychiatria Danubina (2021) Vol. 33, Iss. 2, pp. 198-199
Open Access | Times Cited: 3
Mirtazapine-related manic / hypomanic shift: mini review and case report
Mustafa Dinçer, Ahmet Gül, Hesna Gül, et al.
Dusunen Adam The Journal of Psychiatry and Neurological Sciences (2018), pp. 209-214
Open Access | Times Cited: 2
Lumateperone for major depressive episodes in bipolar I or bipolar II disorder
Meyer
Current psychiatry (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 1
The Efficacy Story

Cambridge University Press eBooks (2023), pp. 24-94
Closed Access
Lumateperone for major depressive episodes in bipolar I or bipolar II disorder
Jonathan M. Meyer
Current psychiatry (2022) Vol. 21, Iss. 3
Open Access
Imipramine can be effective on depressive-like behaviors, but not on neurotrophic factors levels in an animal model of bipolar disorder induced by ouabain
Taise Possamai‐Della, Gustavo C. Dal‐Pont, Wilson R. Resende, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top